VYLOY, illustration of injection vial form (not a photo of the actual pack)

Illustrative image.

VYLOY

Zolbetuximab‑clzb

Prescription required

$1231.00

100mg · 1 vial

BrandBranded medicine· By Astellas Pharma

Choose a pack

  • Selected pack

Packs in this delivery

1

Test mode: no payment is taken. View cart

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

About VYLOY

Overview

VYLOY (zolbetuximab-clzb) is an antibody medicine given into a vein. It is used with fluoropyrimidine- and platinum-containing chemotherapy as the first treatment for adults with stomach or gastroesophageal junction adenocarcinoma that has spread nearby and cannot be removed by surgery, or has spread to other parts of the body. The cancer must be HER2-negative and test positive for claudin 18.2 using an FDA-approved test. VYLOY targets claudin 18.2 on cells and activates immune processes that destroy those cells.

What it treats

First-line treatment of adults with HER2-negative, claudin 18.2-positive adenocarcinoma of the stomach or gastroesophageal junction that is locally advanced and cannot be removed by surgery, or has spread to other parts of the body. Used with fluoropyrimidine- and platinum-containing chemotherapy. Claudin 18.2 status must be confirmed by an FDA-approved test.

Safety information

Side effects

Common side effects reported when VYLOY was used with mFOLFOX6 or CAPOX chemotherapy include nausea, vomiting, tiredness, reduced appetite, diarrhea, numbness or tingling from nerve damage, abdominal pain, constipation, weight loss, allergic reactions and fever. Common blood test changes include reduced blood cell counts, low albumin, increased creatinine, raised liver enzymes, high or low blood sugar, and low sodium, phosphate, potassium or magnesium levels. Serious side effects include severe allergic reactions, including anaphylaxis, and reactions related to the infusion. Infusion-related reactions can be fatal. Tell your healthcare team immediately if you develop a reaction during or after an infusion. Patients should be monitored during the infusion and for at least two hours afterward. Severe nausea and vomiting also require prompt contact with your healthcare team. Medicines to prevent nausea and vomiting are given before each infusion. Severe reactions may require the infusion to be interrupted or treatment to be permanently stopped.

When to call your doctor

- Seek medical attention immediately for severe nausea or vomiting. - Get immediate medical help for an allergic reaction or a reaction during or after your VYLOY infusion.

If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.

Before taking this medicine

The label lists no contraindications for VYLOY. Serious allergic reactions, including anaphylaxis, and serious or fatal infusion-related reactions have occurred. Patients must be monitored during the infusion and for at least 2 hours afterward. Depending on the reaction, the healthcare team may pause or slow the infusion, or permanently stop treatment. After an allergic reaction, antihistamines should be given before subsequent infusions. VYLOY can cause severe nausea and vomiting. Medicines to prevent nausea and vomiting should be given before each infusion. Additional treatment or fluid replacement may be needed during and after the infusion. Severe symptoms may require treatment to be paused or permanently stopped. Do not breastfeed during treatment.

Using VYLOY

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store in the original carton below 25°C, protected from light, unless the pack states refrigeration. Do not freeze. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label VYLOY (ZOLBETUXIMAB) INJECTION, POWDER, FOR SUSPENSION [ASTELLAS PHARMA US, INC.] (DailyMed, retrieved 19 September 2026).

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines